VivoSeq
Other

Muscle Relaxant

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Muscle Relaxant is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

9

clinical trials

Completed5 · 56%
Unknown status3 · 33%
Not yet recruiting1 · 11%

Clinical Trials

Trial Activity

9 trials

Muscle Relaxant Effect and Safety of Mivacurium Chloride and Succinylcholine for Bronchoscopy
Not yet recruiting·—·N/A·NCT06709066·240 enrolled
Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium
Completed·UUniversity of California, San Francisco·Phase 1·NCT01906528·20 enrolled
Remifentanil Without Muscle Relaxant for Thoracotomy
Completed·IImam Abdulrahman Bin Faisal University·Phase 2·NCT02030808·66 enrolled
0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant
Completed·MMahidol University·Phase 4·NCT02186132·40 enrolled
Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant
Completed·MMemorial Sloan Kettering Cancer Center·Phase 3·NCT03116997·201 enrolled
Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant
Completed·NNantes University Hospital·Phase 3·NCT03960801·1,150 enrolled
Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm Neonates
Unknown status·—·N/A·NCT04566796·60 enrolled
The Effect of no Muscle Relaxant Versus Reduced-dose Rocuronium on Anesthesia in Adenotonsillectomy
Unknown status·KKorea University Anam Hospital·Phase 4·NCT02467595·75 enrolled
Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant on Sore Throat and Hemodynamics
Unknown status·OOstfold Hospital Trust·Phase 4·NCT03031808·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)